SEC Filing Summary: Form 6-K
Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV, a foreign private issuer, for the month of November 2018. The filing, dated November 26, 2018, serves to incorporate by reference a press release (Exhibit 99.1) issued on the same date. The registrant is incorporated in Belgium and files annual reports on Form 20-F. Note: The request metadata references "Lakefront Biotherapeutics NV," but the filing text explicitly identifies the registrant as "Galapagos NV."
Key Financial Metrics
The filing text does not provide specific financial data. This document is a procedural filing to distribute a press release and does not contain revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The filing does not disclose specific material changes to financial position or operations within the text provided. It solely references the issuance of a press release attached as Exhibit 99.1, the content of which is not included in the source text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It notes that the information in the attached press release is incorporated by reference into various Registration Statements (Forms F-3 and S-8).
Investor Verification Checklist
- Verify the content of the attached Exhibit 99.1 (Press Release dated November 26, 2018) to understand the material event triggering this filing.
- Confirm the registrant identity is Galapagos NV and not Lakefront Biotherapeutics NV, as the filing text explicitly names Galapagos.
- Review the referenced Registration Statements (File Nos. 333-211765, 333-204567, etc.) for updated disclosures regarding the press release content.